{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T20:15:39Z","timestamp":1788293739078,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK060414"],"award-info":[{"award-number":["T32DK060414"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK139455"],"award-info":[{"award-number":["K23DK139455"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["P30DK026743"],"award-info":[{"award-number":["P30DK026743"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24AG080021"],"award-info":[{"award-number":["K24AG080021"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","award":["PSC Partners Young Investigator Award"],"award-info":[{"award-number":["PSC Partners Young Investigator Award"]}],"id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"DOI":"10.1007\/s10620-026-10216-0","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:35:21Z","timestamp":1788291321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of Primary Sclerosing Cholangitis: ICD-10 Code Validation and Comparison with a Large Language Model Approach"],"prefix":"10.1007","author":[{"given":"Melinda","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Dao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Delk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica B.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer C.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"10216_CR1","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","volume":"56","author":"K Boonstra","year":"2012","unstructured":"Boonstra K, Beuers U, Ponsioen CY. Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review. J Hepatol 2012;56:1181\u20131188.","journal-title":"J Hepatol"},{"key":"10216_CR2","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson JK, Beuers U, Jones DE, Lohse AW, Hudson M. Primary sclerosing cholangitis. The Lancet 2018;391:2547\u20132559.","journal-title":"The Lancet"},{"key":"10216_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/hep.23294","volume":"51","author":"R Chapman","year":"2010","unstructured":"Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B et al. Diagnosis and management of primary sclerosing cholangitis. Hepatology 2010;51:660\u2013678.","journal-title":"Hepatology"},{"key":"10216_CR4","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1111\/liv.12775","volume":"35","author":"J Haapam\u00e4ki","year":"2015","unstructured":"Haapam\u00e4ki J, Tenca A, Sintonen H, Barner-Rasmussen N, F\u00e4rkkil\u00e4 MA. Health-related quality of life among patients with primary sclerosing cholangitis. Liver Int 2015;35:2194\u20132201.","journal-title":"Liver Int"},{"key":"10216_CR5","doi-asserted-by":"publisher","first-page":"S338","DOI":"10.1016\/S0168-8278(22)01039-X","volume":"77","author":"B Mol","year":"2022","unstructured":"Mol B, van Munster K, Bogaards J, Weersma R, Inderson A, de Groof J et al. Health-related quality of life in patients with primary sclerosing cholangitis: a longitudinal population-based cohort study. J Hepatol 2022;77:S338\u2013S339.","journal-title":"J Hepatol"},{"key":"10216_CR6","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","volume":"20","author":"PJ Trivedi","year":"2022","unstructured":"Trivedi PJ, Bowlus CL, Yimam KK, Razavi H, Estes C. Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies. Clin Gastroenterol Hepatol 2022;20:1687\u2013700.e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10216_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-230X-11-83","volume":"11","author":"E Toy","year":"2011","unstructured":"Toy E, Balasubramanian S, Selmi C, Li C-S, Bowlus CL. The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population. BMC Gastroenterol 2011;11:1\u20137.","journal-title":"BMC Gastroenterol"},{"key":"10216_CR8","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.cgh.2022.09.001","volume":"21","author":"M Wang","year":"2022","unstructured":"Wang M, Auerbach A, Oreper SM, Hohmann SF, Lai JC, Rubin JB. Leveraging a new ICD-10 diagnosis code to characterize hospitalized patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2022;21:2692\u20132694.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10216_CR9","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1111\/liv.15007","volume":"41","author":"TI Mehta","year":"2021","unstructured":"Mehta TI, Weissman S, Fung BM, Sotiriadis J, Lindor KD, Tabibian JH. Global incidence, prevalence and features of primary sclerosing cholangitis: a systematic review and meta-analysis. Liver Int 2021;41:2418\u20132426.","journal-title":"Liver Int"},{"key":"10216_CR10","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1478-3231.2011.02484.x","volume":"31","author":"NA Molodecky","year":"2011","unstructured":"Molodecky NA, Myers RP, Barkema HW, Quan H, Kaplan GG. Validity of administrative data for the diagnosis of primary sclerosing cholangitis: a population-based study. Liver Int 2011;31:712\u2013720.","journal-title":"Liver Int"},{"key":"10216_CR11","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1053\/j.gastro.2021.07.046","volume":"161","author":"CY Ponsioen","year":"2021","unstructured":"Ponsioen CY, Assis DN, Boberg KM, Bowlus CL, Deneau M, Thorburn D et al. Defining primary sclerosing cholangitis: results from an international primary sclerosing cholangitis study group consensus process. Gastroenterology 2021;161:1764\u201375.e5.","journal-title":"Gastroenterology"},{"key":"10216_CR12","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1002\/lt.22161","volume":"16","author":"CL Bowlus","year":"2010","unstructured":"Bowlus CL, Li CS, Karlsen TH, Lie BA, Selmi C. Primary sclerosing cholangitis in genetically diverse populations listed for liver transplantation: unique clinical and human leukocyte antigen associations. Liver Transplant 2010;16:1324\u20131330.","journal-title":"Liver Transplant"},{"key":"10216_CR13","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1111\/liv.15008","volume":"41","author":"VS Are","year":"2021","unstructured":"Are VS, Vilar-Gomez E, Gromski MA, Akisik F, Lammert C, Ghabril M et al. Racial differences in primary sclerosing cholangitis mortality is associated with community socioeconomic status. Liver Int 2021;41:2703\u20132711.","journal-title":"Liver Int"},{"key":"10216_CR14","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.cgh.2022.09.001","volume":"21","author":"M Wang","year":"2023","unstructured":"Wang M, Auerbach A, Oreper SM, Hohmann SF, Lai JC, Rubin JB. Leveraging a new ICD-10 diagnosis code to characterize hospitalized patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 2023;21:2692\u20132694.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10216_CR15","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.aohep.2025.101901","volume":"30","author":"M Wang","year":"2025","unstructured":"Wang M, Harris A, McCulloch CE, Wadhwani SI, Lai JC, Rubin JB. Racial differences in primary sclerosing cholangitis: A retrospective cohort study leveraging a new ICD-10 code. Ann Hepatol 2025;30:101901.","journal-title":"Ann Hepatol"},{"key":"10216_CR16","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1097\/HEP.0000000000001115","volume":"81","author":"AT Far","year":"2025","unstructured":"Far AT, Bastani A, Lee A, Gologorskaya O, Huang CY, Pletcher MJ et al. Evaluating the positive predictive value of code-based identification of cirrhosis and its complications utilizing GPT-4. Hepatology 2025;81:1753\u20131763.","journal-title":"Hepatology"},{"key":"10216_CR17","doi-asserted-by":"publisher","first-page":"e72984","DOI":"10.2196\/72984","volume":"27","author":"AJ McMurry","year":"2025","unstructured":"McMurry AJ, Phelan D, Dixon BE, Geva A, Gottlieb D, Jones JR et al. Large language model symptom identification from clinical text: multicenter study. J Med Internet Res 2025;27:e72984.","journal-title":"J Med Internet Res"},{"key":"10216_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"JH Friedman","year":"2010","unstructured":"Friedman JH, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw 2010;33:1\u201322.","journal-title":"J Stat Softw"},{"key":"10216_CR19","doi-asserted-by":"publisher","first-page":"1076788","DOI":"10.3389\/fgstr.2022.1076788","volume":"1","author":"A Nguyen","year":"2023","unstructured":"Nguyen A, TorabiSagvand B, Alizadeh M, Nguyen C, Scott W, von Rosenvinge EC. Primary sclerosing cholangitis and pancreatic cancer: a retrospective cohort study of United States veterans. Front Gastroenterol 2023;1:1076788.","journal-title":"Front Gastroenterol"},{"key":"10216_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/apt.16296","volume":"53","author":"A Mazhar","year":"2021","unstructured":"Mazhar A, Russo MW. Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis. Aliment Pharmacol Therap 2021;53:774\u2013783.","journal-title":"Aliment Pharmacol Therap"},{"key":"10216_CR21","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1007\/s00330-020-07323-5","volume":"31","author":"KI Ringe","year":"2021","unstructured":"Ringe KI, Vo Chieu VD, Wacker F, Lenzen H, Manns MP, Hundt C et al. Fully automated detection of primary sclerosing cholangitis (PSC)-compatible bile duct changes based on 3D magnetic resonance cholangiopancreatography using machine learning. Eur Radiol 2021;31:2482\u20132489.","journal-title":"Eur Radiol"},{"key":"10216_CR22","doi-asserted-by":"publisher","first-page":"e220160","DOI":"10.1148\/ryai.220160","volume":"5","author":"H Ragab","year":"2023","unstructured":"Ragab H, Westhaeusser F, Ernst A, Yamamura J, Fuhlert P, Zimmermann M et al. DeePSC: A deep learning model for automated diagnosis of primary sclerosing cholangitis at two-dimensional MR cholangiopancreatography. Radiol Artif Intell 2023;5:e220160.","journal-title":"Radiol Artif Intell"},{"key":"10216_CR23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/hep.30085","volume":"71","author":"JE Eaton","year":"2020","unstructured":"Eaton JE, Vesterhus M, McCauley BM, Atkinson EJ, Schlicht EM, Juran BD et al. Primary sclerosing cholangitis risk estimate tool (PREsTo) predicts outcomes of the disease: a derivation and validation study using machine learning. Hepatology. 2020;71:214\u2013224.","journal-title":"Hepatology."},{"key":"10216_CR24","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.mcpdig.2024.07.002","volume":"2","author":"Y Singh","year":"2024","unstructured":"Singh Y, Faghani S, Eaton JE, Venkatesh SK, Erickson BJ. Deep learning\u2013based prediction of hepatic decompensation in patients with primary sclerosing cholangitis with computed tomography. Mayo Clin Proc Digit Health 2024;2:470\u2013476.","journal-title":"Mayo Clin Proc Digit Health"},{"key":"10216_CR25","doi-asserted-by":"publisher","first-page":"e1774","DOI":"10.1097\/TXD.0000000000001774","volume":"11","author":"X Zhao","year":"2025","unstructured":"Zhao X, Naghibzadeh M, Sun Y, Rahmani A, Lilly L, Selzner N et al. Machine learning prediction model of waitlist outcomes in patients with primary sclerosing cholangitis. Transplant Direct 2025;11:e1774.","journal-title":"Transplant Direct"},{"key":"10216_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/MEG.0000000000000532","volume":"28","author":"RE Rossi","year":"2016","unstructured":"Rossi RE, Conte D, Massironi S. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update. Eur J Gastroenterol Hepatol 2016;28:123\u2013131.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10216_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1136\/gut.2004.046615","volume":"54","author":"E Loftus","year":"2005","unstructured":"Loftus E, Harewood G, Loftus C, Tremaine W, Harmsen W, Zinsmeister A et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91\u201396.","journal-title":"Gut."},{"key":"10216_CR28","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS et al. High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009;50:808\u2013814.","journal-title":"Hepatology"},{"key":"10216_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.coph.2021.11.003","volume":"62","author":"N Abbas","year":"2022","unstructured":"Abbas N, Quraishi MN, Trivedi P. Emerging drugs for the treatment of primary sclerosing cholangitis. Curr Opin Pharmacol 2022;62:23\u201335.","journal-title":"Curr Opin Pharmacol"},{"key":"10216_CR30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54:374\u2013385.","journal-title":"J Hepatol"},{"key":"10216_CR31","first-page":"e7298","volume":"12","author":"S Deliwala","year":"2020","unstructured":"Deliwala S, Sundus S, Haykal T, Elbedawi MM, Bachuwa G. Small duct primary sclerosing cholangitis: an underdiagnosed cause of chronic liver disease and cirrhosis. Cureus. 2020;12:e7298.","journal-title":"Cureus."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-10216-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-10216-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:35:23Z","timestamp":1788291323000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-10216-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":31,"alternative-id":["10216"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-10216-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors of this manuscript have the following potential conflicts of interest to disclose as described by Dr. Jin Ge previously received research support (to institution) from Merck and Co. He previously served on an advisory board for Gilead Sciences and previously consulted for Madrigal Pharmaceuticals and Astellas Pharmaceuticals\/Iota Biosciences. Dr. Jennifer C. Lai receives research support (to institution) from Lipocene and Gore Medical; serves on an advisory board for Boehringer Ingelheim, Cosmo; and consults for Novo Nordisk. Dr. Michael Li receives research support (to institution) from FUJIFILM Wako and previously consulted for Ono Pharmaceuticals.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}